David Sidransky - 31 Dec 2021 Form 5 Insider Report for Orgenesis Inc. (ORGS)

Role
Director
Signature
/s/ David Sidransky
Issuer symbol
ORGS
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
14 Feb 2022, 15:50:05 UTC
Previous filing
09 Nov 2021
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGS Stock Option (Right to Buy) Award $0 +2,045 +11% $0.000000 20,450 16 Dec 2021 Common Stock 20,450 $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 16, 2021, the Board granted the Reporting Person options to purchase 20,450 shares at the exercise price of $2.89 per share. The options vest in full one year from the date of grant.